Gabriela K Fragiadakis1, Brice Gaudillière, Edward A Ganio, Nima Aghaeepour, Martha Tingle, Garry P Nolan, Martin S Angst. 1. From the Baxter Laboratory in Stem Cell Biology, Stanford University, Stanford, California (G.K.F., B.G., N.A., G.P.N.); Department of Microbiology and Immunology, Stanford University, Stanford, California (G.K.F., G.P.N.); and Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California (B.G., E.A.G., M.T., M.S.A.).
Abstract
BACKGROUND: Recovery after surgery is highly variable. Risk-stratifying patients based on their predicted recovery profile will afford individualized perioperative management strategies. Recently, application of mass cytometry in patients undergoing hip arthroplasty revealed strong immune correlates of surgical recovery in blood samples collected shortly after surgery. However, the ability to interrogate a patient's immune state before surgery and predict recovery is highly desirable in perioperative medicine. METHODS: To evaluate a patient's presurgical immune state, cell-type-specific intracellular signaling responses to ex vivo ligands (lipopolysaccharide, interleukin [IL]-6, IL-10, and IL-2/granulocyte macrophage colony-stimulating factor) were quantified by mass cytometry in presurgical blood samples. Selected ligands modulate signaling processes perturbed by surgery. Twenty-three cell surface and 11 intracellular markers were used for the phenotypic and functional characterization of major immune cell subsets. Evoked immune responses were regressed against patient-centered outcomes, contributing to protracted recovery including functional impairment, postoperative pain, and fatigue. RESULTS: Evoked signaling responses varied significantly and defined patient-specific presurgical immune states. Eighteen signaling responses correlated significantly with surgical recovery parameters (|R| = 0.37 to 0.70; false discovery rate < 0.01). Signaling responses downstream of the toll-like receptor 4 in cluster of differentiation (CD) 14 monocytes were particularly strong correlates, accounting for 50% of observed variance. Immune correlates identified in presurgical blood samples mirrored correlates identified in postsurgical blood samples. CONCLUSIONS: Convergent findings in pre- and postsurgical analyses provide validation of reported immune correlates and suggest a critical role of the toll-like receptor 4 signaling pathway in monocytes for the clinical recovery process. The comprehensive assessment of patients' preoperative immune state is promising for predicting important recovery parameters and may lead to clinical tests using standard flow cytometry.
BACKGROUND: Recovery after surgery is highly variable. Risk-stratifying patients based on their predicted recovery profile will afford individualized perioperative management strategies. Recently, application of mass cytometry in patients undergoing hip arthroplasty revealed strong immune correlates of surgical recovery in blood samples collected shortly after surgery. However, the ability to interrogate a patient's immune state before surgery and predict recovery is highly desirable in perioperative medicine. METHODS: To evaluate a patient's presurgical immune state, cell-type-specific intracellular signaling responses to ex vivo ligands (lipopolysaccharide, interleukin [IL]-6, IL-10, and IL-2/granulocyte macrophage colony-stimulating factor) were quantified by mass cytometry in presurgical blood samples. Selected ligands modulate signaling processes perturbed by surgery. Twenty-three cell surface and 11 intracellular markers were used for the phenotypic and functional characterization of major immune cell subsets. Evoked immune responses were regressed against patient-centered outcomes, contributing to protracted recovery including functional impairment, postoperative pain, and fatigue. RESULTS: Evoked signaling responses varied significantly and defined patient-specific presurgical immune states. Eighteen signaling responses correlated significantly with surgical recovery parameters (|R| = 0.37 to 0.70; false discovery rate < 0.01). Signaling responses downstream of the toll-like receptor 4 in cluster of differentiation (CD) 14 monocytes were particularly strong correlates, accounting for 50% of observed variance. Immune correlates identified in presurgical blood samples mirrored correlates identified in postsurgical blood samples. CONCLUSIONS: Convergent findings in pre- and postsurgical analyses provide validation of reported immune correlates and suggest a critical role of the toll-like receptor 4 signaling pathway in monocytes for the clinical recovery process. The comprehensive assessment of patients' preoperative immune state is promising for predicting important recovery parameters and may lead to clinical tests using standard flow cytometry.
Authors: Jin Mo Park; Florian R Greten; Athena Wong; Randal J Westrick; J Simon C Arthur; Kinya Otsu; Alexander Hoffmann; Marc Montminy; Michael Karin Journal: Immunity Date: 2005-09 Impact factor: 31.745
Authors: Adrian A Maung; Satoshi Fujimi; Marissa L Miller; Malcolm P MacConmara; John A Mannick; James A Lederer Journal: J Leukoc Biol Date: 2005-04-27 Impact factor: 4.962
Authors: Ingrid E Dumitriu; Paramita Baruah; Barbara Valentinis; Reinhard E Voll; Martin Herrmann; Peter P Nawroth; Bernd Arnold; Marco E Bianchi; Angelo A Manfredi; Patrizia Rovere-Querini Journal: J Immunol Date: 2005-06-15 Impact factor: 5.422
Authors: M Ditschkowski; E Kreuzfelder; V Rebmann; S Ferencik; M Majetschak; E N Schmid; U Obertacke; H Hirche; U F Schade; H Grosse-Wilde Journal: Ann Surg Date: 1999-02 Impact factor: 12.969
Authors: Gabriela K Fragiadakis; Quentin J Baca; Pier Federico Gherardini; Edward A Ganio; Dyani K Gaudilliere; Martha Tingle; Hope L Lancero; Leslie S McNeil; Matthew H Spitzer; Ronald J Wong; Gary M Shaw; Gary L Darmstadt; Karl G Sylvester; Virginia D Winn; Brendan Carvalho; David B Lewis; David K Stevenson; Garry P Nolan; Nima Aghaeepour; Martin S Angst; Brice L Gaudilliere Journal: J Immunol Date: 2016-10-28 Impact factor: 5.422
Authors: Nima Aghaeepour; Cindy Kin; Edward A Ganio; Kent P Jensen; Dyani K Gaudilliere; Martha Tingle; Amy Tsai; Hope L Lancero; Benjamin Choisy; Leslie S McNeil; Robin Okada; Andrew A Shelton; Garry P Nolan; Martin S Angst; Brice L Gaudilliere Journal: J Immunol Date: 2017-08-09 Impact factor: 5.422
Authors: Martin S Angst; Gabriela K Fragiadakis; Brice Gaudillière; Nima Aghaeepour; Garry P Nolan Journal: Anesthesiology Date: 2016-06 Impact factor: 7.892
Authors: Vidya Chidambaran; Xue Zhang; Valentina Pilipenko; Xiaoting Chen; Benjamin Wronowski; Kristie Geisler; Lisa J Martin; Artem Barski; Matthew T Weirauch; Hong Ji Journal: Epigenomics Date: 2021-04-06 Impact factor: 4.778